NO EFFECT OF PROTEIN SUPPLEMENTATION ON BONE MINERAL DENSITY IN PROSTATE CANCER PATIENTS ON ANDROGEN DEPRIVATION THERAPY

被引:0
|
作者
Groenendijk, I. [1 ]
Houben, L. H. P. [2 ]
Overkamp, M. [2 ]
van Loon, L. J. C. [2 ]
Beelen, M. [2 ]
Beijer, S. [3 ]
De Groot, L. [1 ]
机构
[1] Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands
[2] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands
[3] Netherlands Comprehens Canc Org, Wageningen, Netherlands
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
P719
引用
收藏
页码:S376 / S376
页数:1
相关论文
共 50 条
  • [41] Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab
    Miyazawa, Yoshiyuki
    Sekine, Yoshitaka
    Syuto, Takahiro
    Nomura, Masashi
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Ito, Kazuto
    Suzuki, Kazuhiro
    [J]. ANTICANCER RESEARCH, 2017, 37 (07) : 3667 - 3671
  • [42] Decreases of bone mineral density (BMD) in non-metastatic prostate cancer patients treated with androgen deprivation therapy (ADT)
    Kato, S.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 104 - 104
  • [43] Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer
    Ryan, Christopher W.
    Huo, Dezheng
    Demers, Laurence M.
    Beer, Tomasz M.
    Lacerna, Leo V.
    [J]. JOURNAL OF UROLOGY, 2006, 176 (03): : 972 - 978
  • [44] Bone mineral density in prostate cancer patients undergoing initial androgen deprivation therapy: Zoledronic acid vs. placebo
    Israeli, RS
    Rosenberg, S
    Saltzstein, D
    Gottesman, JE
    Goldstein, HB
    Hull, G
    Tran, D
    Warsi, G
    Lacema, LV
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 134 - 134
  • [45] Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy
    Ryan, Christopher W.
    Huo, Dezheng
    Stallings, James W.
    Davis, Ronald L.
    Beer, Tomasz M.
    McWhorter, Laura T.
    [J]. UROLOGY, 2007, 70 (01) : 122 - 126
  • [46] Evaluation of bone mass density on patients with prostate cancer prior to the start of androgen deprivation therapy
    Ziaran, S.
    Goncalves, F. M.
    Wendl, J.
    Trebaticky, B.
    Breza, J. Sn
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2009, 110 (09): : 559 - 562
  • [47] Effect of muscle density in patients with metastatic prostate cancer administered androgen deprivation therapy
    Munoz-Rodriguez, Jesus
    Dominguez, Arturo
    Rosado, Mario A.
    Centeno, Clara
    Parejo, Victor
    Costa-Trachsel, Irmgard
    Gallardo, Enrique
    Bonfill, Teresa
    Garcia-Rojo, Dario
    De Verdonces, Leticia
    Prats, Joan
    [J]. ENDOCRINOLOGIA DIABETES Y NUTRICION, 2021, 68 (02): : 92 - 98
  • [48] Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer
    Vahakn B. Shahinian
    Yong-Fang Kuo
    [J]. Journal of General Internal Medicine, 2013, 28 : 1440 - 1446
  • [49] Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer
    Shahinian, Vahakn B.
    Kuo, Yong-Fang
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (11) : 1440 - 1446
  • [50] Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer
    R B Egerdie
    F Saad
    M R Smith
    T L J Tammela
    J Heracek
    P Sieber
    C Ke
    B Leder
    R Dansey
    C Goessl
    [J]. Prostate Cancer and Prostatic Diseases, 2012, 15 : 308 - 312